Echo Therapeutics Inc fka ECTE

[ramad]

Sorry to say your opinion has no logic. Why would investor want to change management if the CGM was sufficient and workable to go forward with clinical trials. CEO most likely was forced to resign because progress was very slow in development of a workable CGM. Any new funds to echo plus financing the clinical trials plus mfg the CGM would cost the investor/Mtia perhaps upwards of over 10M. It is only prudent business sense to be sure they have a CGM that will definitely pass the requirements to get CFDA approval.I agree with you that they made stipulations to echo such as cutting their budget.Bottom line I would rather risk $250,000 versus 10M to know if Echo new CGM model is workable. Everything else does not matter. In my opinion we will know within the next 45 days.